Stock Taper
ACONW
ACLARION, INC.
NASDAQ
$0.04
▲ UP 13.64% (0.00)

KEY STATISTICS

Market Cap$16.43 K
52w High$0.05
52w Low$0.03
Dividend Yield
Frequency
P/E
Volume756
Shares Out.533.31K

COMPANY

LEADERSHIP

Brent Ness
CHIEF EXECUTIVE
Brent Ness

COMPENSATION 2026

Salary$300,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$462,500

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 22, 2022
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
11

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$40.00K
DEC
2
WED

PRICE

$0.04 ▲ UP 13.64% (+$0.00)
$0.03$0.03$0.03$0.049:30 AM9:57 AM10:24 AM10:50 AM11:17 AM11:44 AM12:11 PM0.04

About Aclarion, Inc.

https://www.aclarion.com ↗

Aclarion, Inc. develops healthcare software for magnetic resonance spectroscopy, including tools for analyzing pain biomarkers and clinical decision support, based in San Mateo, California.

INDUSTRY

Medical - Healthcare Information Services

A SERVICE ACLARION, INC. IS KNOWN FOR

Nociscan

Nociscan is a SaaS platform that uses MRS and proprietary algorithms to noninvasively identify pain-causing intervertebral discs, providing biomarker data to optimize treatment for degenerative spine disease.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR
Williams Amanda M
Purchase · 5.9K shares
2026-08-17
OFFICER: CFO
Gould Gregory A
Purchase · 10.0K shares
2026-08-14
DIRECTOR
Neal David K
Purchase · 7.5K shares
2026-08-13
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Ness Brent
Purchase · 5.2K shares
2026-08-13